88IV - Public company info - Ascentage Pharma Group International

Input the stock code or the company name

Ascentage Pharma Group International, 06855.HK - Cash Flow	2022-12	2021-12	2020-12	2019-12	2018-12	2017-12	2016-12
Net Cash Flow from Operating Activities	-653,915	-600,833	-609,956	-460,305	-237,667	-107,985	-45,893
Net Cash Flow from Return on Investments & Servicing of Finance	-49,849	-16,808	-5,935	-4,268	-1,892	-257	-49
Interest Received	0	0	0	0	0	0	0
Interest Paid	-49,849	-16,808	-5,935	-4,268	-1,892	-257	-49
Dividend Received	0	0	0	0	0	0	0
Dividend Paid	0	0	0	0	0	0	0
Others	0	0	0	0	0	0	0
Taxes (Paid) / Refunded	0	-3,846	0	0	0	0	0
Net Cash Flow from Investing Activities	-384,612	-466,522	-107,367	-201,333	292,808	-230,347	-152,611
Additions to Fixed Assets	-203,288	-435,415	-249,921	-77,456	-14,257	-20,536	-3,285
Disposal of Fixed Assets	2,351	335	0	0	2	13	7
Increase in Investments	-20,000	-1,820,016	-2,170,111	-1,806,601	342,266	-209,824	-149,247
Decrease in Investments	0	1,789,788	2,174,696	1,826,208	0	0	0
Net Cash Flow with Related Parties	0	0	0	0	0	0	0
Others	-163,675	-1,214	137,969	-143,484	-35,203	0	-86
Net Cash Flow before Financing Activities	-1,088,376	-1,088,009	-723,258	-665,906	53,249	-338,589	-198,553
Net Cash Flow from Financing Activities	669,117	1,798,195	1,045,938	446,630	862,055	58,619	435,584
New Loans	763,617	599,737	527,805	85,000	85,000	0	0
Loans Repayment	-67,743	-60,242	-102,670	-42,660	-53,339	-2,274	-532
Fixed Income/Debt Instruments	0	0	0	0	0	0	0
Repayment of Fixed Income/Debt Instruments	0	0	0	0	0	0	0
Equity Financing	19	1,284,574	620,803	404,290	910,616	60,893	436,116
Net Cash Flow with Related Parties	0	0	0	0	0	0	0
Others	-26,776	-25,874	0	0	-80,222	0	0
Increase(Decrease) in Cash & Cash Equivalents	-419,259	710,186	322,680	-219,276	915,304	-279,970	237,031
Cash & Cash Equivalents at Beginning of Year	1,706,886	1,019,979	738,986	957,088	14,821	294,529	57,602
Net Cash Flow due to Change in Exchange Rate/Others	58,012	-23,279	-41,687	1,174	26,963	262	-104
Cash & Cash Equivalents at End of Year	1,345,639	1,706,886	1,019,979	738,986	957,088	14,821	294,529
Currency	Renminbi	Renminbi	Renminbi	Renminbi	Renminbi	Renminbi	Renminbi
Unit
Auditor's Opinion	1	1	1	1	0	0	0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

88iv | Home | Login

Mobile | Full

Suntek Computer Systems Limited.

Public company info - Ascentage Pharma Group International , 06855.HK